相关实验视频

Updated: Jun 15, 2025

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD

Published on: March 12, 2020

在重大抑郁症中,对抗抑郁药物的早期反应的电生理学预测因素

Hao Tang¹, Yi Xia¹, Lingling Hua¹

¹Department of Psychiatry, the Affiliated Brain Hospital of Nanjing Medical University, Nanjing 210029, China.

Journal of affective disorders

|August 26, 2024

概括

大型抑郁症 (MDD) 中的精神运动迟缓与抗抑郁药反应不佳有关. 通过磁脑图 (MEG) 检测到的特定运动网络异常可以预测MDD患者的治疗结果.

科学领域:

神经科学是一个神经科学.
精神病学是一个精神病学.
生物标志物生物标志物

背景情况:

精神运动迟缓 (PMR) 是主要抑郁症 (MDD) 的一个关键症状,影响运动控制和认知.
在MDD中,PMR与抗抑郁药治疗的反应减弱有关.
关联PMR与MDD治疗结果的精确神经支尚未完全理解.

研究的目的:

调查与MDD患者抗抑郁药反应不佳相关的电生理学生物标志物.
探索运动网络功能与抑郁症治疗结果之间的关系.

主要方法:

磁脑电图 (MEG) 用于在视觉运动任务期间记录93名MDD患者和49名健康对照者的大脑活动.
测量了与机动有关的β脱同步 (MRBD) 和机动网络内的功能连接.
抗抑郁药物反应被定义为治疗后≥50%的症状严重程度降低.

主要成果:

与响应者和HC相比,非响应者在汽车网络中显示出增加的MRBD和减少的半球间和半球内功能连接.
发现这些运动网络调节障碍可以预测抗抑郁药治疗反应.
在治疗结果不佳的患者中观察到局部运动网络活动和连接的异常.

结论:

改变的运动网络活动和连接性表明MDD中的精神运动功能差.
这些神经特征可能导致对抗抑郁药疗法的敏感性降低.
运动网络中的电生理学标记显示出在MDD中预测抗抑郁药治疗反应的潜力.

关键词:

抗抑郁药物反应的反应半球间和半球内部的功能连接性.磁性脑电图 (MEG) 是一种磁性脑电图.大型抑郁症主要是抑郁症.与运动相关的β脱同步.

更多相关视频

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...